About ChemNavigator
ChemNavigator is a Healthcare company based in Milwaukee (United States) founded in 1999, and was acquired by Sigma Aldrich in August 2009. It operates as a solutions and services to aid research organizations identify and procure the chemistry they need for drug discovery and agrochemical research. It operates in the Healthcare and Technology sectors. ChemNavigator has raised $8.75 million across 3 funding rounds from investors including United Overseas Bank, Sigma Aldrich and Life Sciences Partners. The company was acqui-hired. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is Chemnavigator, Inc. Its competitors include Insitro, HotSpot Therapeutics, TOLREMO therapeutics, Certara and Inpharmatica and 5 more; 7 of its 10 listed competitors have raised funding.
Company details
ChemNavigator provides solutions and services to aid research organizations identify and procure the chemistry they need for drug discovery and agrochemical research. Products include iResearch Library which tracks over 102 million chemical products and iResearch System which is a chemical substructure and similarity search application for searching ChemNavigators iResearch Library. Database licenses include access to regular updates, sourcing information, and ChemNavigators optional Chemistry Procurement Service. The database may be licensed on CDDVD ROM or accessed through an on-line iResearch System subscription. It also offers services such as virtual screening of over 55.3 million unique chemical structures against a drug target or existing QSAR model, Chemistry Procurement Service and custom development and licensing of their cheminformatics systems and technology to clients who wish to use the technology in their internal systems or commercial products.
- Headquarters Milwaukee, United States
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Website chemnavigator.com
- Social LinkedIn
- Acquired by Sigma Aldrich (Aug 2009)
- Legal Name Chemnavigator, Inc.
- Total Equity Funding$8.75M (USD)
in 3 rounds
- Latest Funding Round$6.25M (USD), Series B
Sep 2000
- InvestorsUnited Overseas Bank
& 4 more
- Acquired bySigma Aldrich
(Aug 2009)
Funding Insights of ChemNavigator
ChemNavigator has successfully raised a total of $8.75M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.25 million completed in September 2000. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.75M
- Total Rounds 3
- Last Round Series B — $6.25M
- First Round $1.25M
(Jun 1999)
- Investors Count 4
All 3 funding rounds of ChemNavigator with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2000 | $6.25M | Series B | – | – | |
| Aug 1999 | $2.5M | Series A | – | – | – |
| Jun 1999 | $1.25M | Unspecified | – | – | – |
5 investors in total: 5 institutional.
Investors in ChemNavigator
ChemNavigator has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include United Overseas Bank, Sigma Aldrich and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | 3vs1.com | - | |
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
- | – | taurusenterprisesinc.com | - | |
Diversified banking and financial services are offered worldwide. | 1935 | uobgroup.com | Singapore, Singapore | |
Biochemical and organic chemicals are developed for scientific research applications. | 1951 | sigmaaldrich.com | St. Louis, United States |
Investor details for ChemNavigator
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ChemNavigator
4 dated milestones of ChemNavigator across 10 years, from founding to its latest funding, stage changes and deals.
- Founded ChemNavigator is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Series B, of $6.2M.
- Exit Acquired by Sigma Aldrich.
Competitors of ChemNavigator
ChemNavigator has 10 listed competitors in our database, 7 of them funded. They include Insitro, HotSpot Therapeutics, TOLREMO therapeutics, Certara and Inpharmatica, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| hotspotthera.com | 2017 | Boston, United States | $210M | 37 | Developer of a platform for protein function analysis | |
| tolremo.com | 2017 | Zurich, Switzerland | $55.81M | – | Anti-cancer small molecules are developed to target drug resistance pathways. | |
| certara.com | 2008 | Princeton, United States | – | 827 | Provider of a platform for in silico drug discovery and consulting services | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| cytoreason.com | 2016 | Haifa, Israel | $100M | – | Immune system-based drugs are discovered via biological data analytics. | |
| grobio.com | 2016 | Boston, United States | $91.15M | 22 | Synthetic biology tools are developed via genetic code recoding techniques. | |
| recludixpharma.com | 2020 | San Diego, United States | $60M | 33 | Provider of the online platform for drug discovery and development | |
| c4xdiscovery.com | 2008 | Manchester, United Kingdom | – | 46 | Developer of optimized drug discovery and design services | |
| postera.ai | 2019 | London, United Kingdom | $26.2M | 3 | AI based molecular designing software for drug discovery |
Detailed competitors of ChemNavigator
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ChemNavigator
Websites that share an audience with ChemNavigator (chemnavigator.com).
Websites whose visitors overlap most with ChemNavigator. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| polyplus-transfection.com | 100% | – | – | View details | |
| viagenbiotech.com | 100% | – | – | View details | |
| mobitec.com | 100% | 9.8K | #2,397,558 | View details | |
| bdbiosciences.com | 100% | 331.8K | #154,504 | View details | |
fastquant.com | fastquant.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for ChemNavigator
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as ChemNavigator (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chemnavigator
Complete news archive for ChemNavigator
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ChemNavigator
ChemNavigator was founded in 1999.
ChemNavigator is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.
ChemNavigator is a funded company, having raised a total of $8.75M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $1.25M, raised on Jun 1999.
ChemNavigator provides solutions and services to aid research organizations identify and procure the chemistry they need for drug discovery and agrochemical research. Products include iResearch Library which tracks over 102 million chemical products and iResearch System which is a chemical substructure and similarity search application for searching ChemNavigators iResearch Library. Database licenses include access to regular updates, sourcing information, and ChemNavigators optional Chemistry Procurement Service. The database may be licensed on CDDVD ROM or accessed through an on-line iResearch System subscription. It also offers services such as virtual screening of over 55.3 million unique chemical structures against a drug target or existing QSAR model, Chemistry Procurement Service and custom development and licensing of their cheminformatics systems and technology to clients who wish to use the technology in their internal systems or commercial products.
ChemNavigator's top competitors include Insitro, HotSpot Therapeutics and Certara.
ChemNavigator has 5 investors. Key investors include United Overseas Bank, Sigma Aldrich, Life Sciences Partners, 3V SouceOne Capital, and taurusenterprisesinc.com.
ChemNavigator operates through Chemnavigator, Inc..
Yes. ChemNavigator was acquired by Sigma Aldrich in August 2009.